Related references
Note: Only part of the references are listed.Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor
Dirk Westermann et al.
BIOLOGICAL CHEMISTRY (2008)
The cardiovascular influence of interleukin-1β on the expression of bradykinin B1 and B2 receptors
A. Riad et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
New perspective on the tissue kallikrein-kinin system in myocardial infarction:: Role of angiogenesis and cardiac regeneration
Dirk Westermann et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy
Dirk Westermann et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy
Dirk Westermann et al.
DIABETES (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
Cecile Cayla et al.
FASEB JOURNAL (2007)
Tissue kallikrein infusion prevents cardiornyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction
Yu-Yu Yao et al.
REGULATORY PEPTIDES (2007)
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects
G. Derosa et al.
DIABETES & METABOLISM (2007)
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy -: The role of angiotensin type 1 receptor antagonism
Dirk Westermann et al.
DIABETES (2007)
Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3 beta activation
Huey-Jiun Li et al.
CARDIOVASCULAR RESEARCH (2007)
Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling
Paolo Madeddu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction
Matthias Koch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus
D. Westermann et al.
DIABETOLOGIA (2006)
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
Julie Chao et al.
BIOLOGICAL CHEMISTRY (2006)
Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells
Izabella Z. A. Pawluczyk et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Diabetic cardiomyopathy
Gregg C. Fonarow et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2006)
Involvement of the NF-κB/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A
E Vellaichamy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats
D Montanari et al.
DIABETES (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor:: Biochemical and pharmacological characterization
J Gougat et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1
HL Hsieh et al.
CELLULAR SIGNALLING (2004)
Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
ZY Fang et al.
ENDOCRINE REVIEWS (2004)
Kinin B1 receptors:: key G-protein-coupled receptors and their role in inflammatory and painful processes
JB Calixto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene
C Tschöpe et al.
FASEB JOURNAL (2004)
Bradykinin increases intracellular calcium levels in rat testis peritubular cells via the B-2 receptor subtype
G Wennemuth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy
F Spillmann et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction
J Agata et al.
HYPERTENSION (2002)
Further pharmacological evidence of nuclear Factor-κB pathway involvement in bradykinin B1 receptor-sensitized responses in human umbilical vein
SP Sardi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems:: Role of ACE inhibition and AT1 receptor blockade
C Tschöpe et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy
B Wielockx et al.
NATURE MEDICINE (2001)
p38 stress-activated protein kinase inhibitor reverses bradykinin B1 receptor-mediated component of inflammatory hyperalgesia
P Ganju et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Association between kinin B1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules
PG McLean et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Functional properties of failing human ventricular myocytes
SR Houser et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2000)
Share Paper
